Literature DB >> 11546972

Reversible hypophosphatemia during moderate hypothermia therapy for brain-injured patients.

M Aibiki1, S Kawaguchi, N Maekawa.   

Abstract

OBJECTIVE: Because plasma potassium, which may similarly change as plasma phosphate (P), decreases during moderate hypothermia, plasma P, a requisite electrolyte for the cell function, may alter during therapeutic moderate hypothermia for brain-injured patients. In 22 such patients who underwent moderate hypothermia or were treated with normothermia, plasma concentrations of P and other chemicals were examined.
DESIGN: A prospective study.
SETTING: The intensive care unit of a medical university hospital. PATIENTS AND
INTERVENTIONS: In 15 consecutive patients with brain injury who underwent moderate hypothermia and 7 serial patients treated with normothermia, plasma concentrations of P, potassium, glucose, blood gas tension and pH, daily urine volume, and water balance were examined. Inequality in the numbers of patients of the two groups was the result of patient exclusion because of multiple trauma, aluminum hydroxide administrations, hyperventilation, preexisting diabetes mellitus, or administration of insulin. Daily blood sampling was done around 8 am. Inclusion criteria included a Glasgow Coma Scale score assessment < or = 8 at admission to the emergency room and evidence of injury on computerized tomography scanning of the brain. MEASUREMENT AND MAIN
RESULTS: Hypothermia decreased plasma P levels as compared with those of normothermia within 4 days after the injury (this period was similar to the duration of the hypothermic phase in the hypothermia group). Such reduction related to changes in blood glucose levels, but not to any in the urine volume, or water balance. The P decrease occurred during the hypothermic phase, but subsequently there was a recovery of P after the rewarming phase. The changes in plasma potassium levels were similar to those in plasma P concentrations during the course. Such changes were accompanied by a recovery of decreased heart rate that occurred during the hypothermic phase.
CONCLUSION: The results suggest that moderate hypothermia of 32-33 degrees C decreases plasma P levels. Further studies are required to examine whether P repletion may overcome certain hemodynamic derangements during moderate hypothermia in brain-injured patients.

Entities:  

Mesh:

Year:  2001        PMID: 11546972     DOI: 10.1097/00003246-200109000-00012

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  8 in total

Review 1.  Application of therapeutic hypothermia in the intensive care unit. Opportunities and pitfalls of a promising treatment modality--Part 2: Practical aspects and side effects.

Authors:  Kees H Polderman
Journal:  Intensive Care Med       Date:  2004-02-06       Impact factor: 17.440

Review 2.  [Controlled mild-to-moderate hypothermia in the intensive care unit].

Authors:  A Brüx; A R J Girbes; K H Polderman
Journal:  Anaesthesist       Date:  2005-03       Impact factor: 1.041

Review 3.  Drug-Induced Hypophosphatemia: Current Insights.

Authors:  Efstathia Megapanou; Matilda Florentin; Haralampos Milionis; Moses Elisaf; George Liamis
Journal:  Drug Saf       Date:  2020-03       Impact factor: 5.606

4.  Unveiling a hidden 31 P signal coresonating with extracellular inorganic phosphate by outer-volume-suppression and localized 31 P MRS in the human brain at 7T.

Authors:  Jimin Ren; Ty Shang; A Dean Sherry; Craig R Malloy
Journal:  Magn Reson Med       Date:  2018-02-09       Impact factor: 4.668

5.  A tertiary care center's experience with therapeutic hypothermia after pediatric cardiac arrest.

Authors:  Ericka L Fink; Robert S B Clark; Patrick M Kochanek; Michael J Bell; R Scott Watson
Journal:  Pediatr Crit Care Med       Date:  2010-01       Impact factor: 3.624

Review 6.  Application of therapeutic hypothermia in the ICU: opportunities and pitfalls of a promising treatment modality. Part 1: Indications and evidence.

Authors:  Kees H Polderman
Journal:  Intensive Care Med       Date:  2004-02-06       Impact factor: 17.440

7.  Electrolyte profiles with induced hypothermia: A sub study of a clinical trial evaluating the duration of hypothermia after cardiac arrest.

Authors:  Hans Kirkegaard; Anders M Grejs; Simon Gudbjerg; Christophe Duez; Anni Jeppesen; Christian Hassager; Timo Laitio; Christian Storm; Fabio Silvio Taccone; Markus B Skrifvars; Eldar Søreide
Journal:  Acta Anaesthesiol Scand       Date:  2022-03-28       Impact factor: 2.274

8.  Comparison of in-hospital and out-of-hospital cardiac arrest patients receiving targeted temperature management: A matched case-control study.

Authors:  Chung-Ting Chen; Cheng-Han Chen; Tzu-Yin Chen; David Hung-Tsang Yen; Chorng-Kuang How; Peter Chuanyi Hou
Journal:  J Chin Med Assoc       Date:  2020-09       Impact factor: 3.396

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.